Table 9.
Year | Tool/Method | Compound | Properties | References |
---|---|---|---|---|
2016 | ACD/I-lab | Angiogenic inhibitor for brain tumor | logS, logP, logD, logBB, hERG inhibition, HBA, HBD, MW | Khan et al., 2016 |
2016 | QikProp 4.6 | N-pyridyl, Pyrimidine benzamides | logS, logBB, MDCK, logKP, metab, CNS, loghERG, HOA | Malik et al., 2016 |
2017 | ACD ChemSketch | Flavonoids | MW, IC50, Index of refraction, Surface tension, Density, Polarity, logP | Das et al., 2017 |
2017 | CoMFA model | CITCO, α-naphtholphthalein, diethylstilbestrol, TPP, phenytoin, (R)-ethotoin, (S)-ethotoin | Drug-drug interactions, logP | Kato et al., 2017 |
2017 | Discovery Studio v3.5 | Novel dibenzofuran derivatives | PSA, Solubility, HIA, Cytochrome P450 2D6, BBB, PPB, Hepatotoxicity | Ma et al., 2017 |
2017 | Self-organizing molecular field analysis (SOMFA) | Curcumin analogs | MW, IC50, logP | Verma and Thareja, 2017 |
2018 | CoMFA and CoMSIA | Scopoletin Phenolic Ether Derivatives | LC50, TPSA | Luo et al., 2018 |
2018 | MLR, SYBYLX v1.3, CoMFA and CoMSIA | Amyloid β aggregation inhibitors | IC50 | Aswathy et al., 2018 |
2018 | Quantum Mechanics/ Molecular Mechanics (QM/MM) | DCHA inhibitors | IC50 | Kollar and Frecer, 2018 |
2018 | QikProp 4.6 | TGF-type I inhibitors | IC50, BBB, logS | Ajay Kumar et al., 2018 |
LogP, octanol-water partition coefficient; LogD, octanol-water distribution coefficient; logS, aqueous solubility; logBB, blood-brain barrier; hERG, human ether-a-go-go related gene block; HOA, human oral absorption; PPB, plasma protein binding; MW, Molecular weight; LC50, median lethal concentration; TPSA, topological polar surface area; PSA, polar surface area; IC50, half maximal inhibitory concentration; HIA, human intestinal absorption; MDCK, madin Darby canine kidney cell line.